Does 4SC (FRA:VSC) Have A Healthy Balance Sheet?
Apr 03
German (DAX) Biotech Industry Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies12
- 7D0.6%
- 3M-10.9%
- 1Y-25.5%
- YTDn/a
The Biotech is pretty flat in the last 7 days, but MorphoSys has stood out, gaining 3.5%. Unfortunately though, the industry is down 24% over the past 12 months. In the next few years, earnings are forecast to decline by 43% annually.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 May 2024 | €2.6b | €884.7m | €188.1m | 10.3x | 13.7x | 2.9x |
| Tue, 16 Apr 2024 | €2.7b | €773.3m | €10.0m | 9x | 265.4x | 3.4x |
| Thu, 14 Mar 2024 | €2.6b | €747.5m | -€56,266,648.80 | 11.4x | -45.4x | 3.4x |
| Sat, 10 Feb 2024 | €2.7b | €746.1m | -€35,822,108.00 | 12.8x | -75.9x | 3.6x |
| Mon, 08 Jan 2024 | €2.8b | €769.9m | -€145,885,802.00 | 13.4x | -19.4x | 3.7x |
| Wed, 06 Dec 2023 | €2.9b | €779.7m | -€160,010,802.00 | 13.5x | -18.3x | 3.7x |
| Fri, 03 Nov 2023 | €3.9b | €1.1b | -€71,826,014.00 | 12.7x | -54.1x | 3.6x |
| Sun, 01 Oct 2023 | €3.9b | €971.6m | -€197,588,171.00 | 10x | -19.6x | 4x |
| Tue, 29 Aug 2023 | €4.0b | €954.6m | -€53,585,517.00 | 19.1x | -74.5x | 4.2x |
| Thu, 27 Jul 2023 | €4.1b | €955.5m | -€219,213,323.00 | 28.7x | -18.9x | 4.3x |
| Sat, 24 Jun 2023 | €4.0b | €967.4m | -€212,883,319.00 | 27.9x | -19x | 4.2x |
| Mon, 22 May 2023 | €4.1b | €967.4m | -€209,726,026.00 | 34.6x | -19.4x | 4.2x |
| Wed, 19 Apr 2023 | €3.6b | €921.4m | -€214,632,794.00 | 13.7x | -16.8x | 3.9x |
| Fri, 17 Mar 2023 | €3.4b | €890.4m | -€225,442,839.00 | 9.9x | -15x | 3.8x |
| Sun, 12 Feb 2023 | €3.0b | €612.2m | -€74,829,428.00 | 10.9x | -40.3x | 4.9x |
| Tue, 10 Jan 2023 | €3.1b | €611.9m | -€53,407,435.00 | 11.9x | -58.4x | 5.1x |
| Thu, 08 Dec 2022 | €3.0b | €611.9m | -€53,407,435.00 | 10.9x | -56.1x | 4.9x |
| Sat, 05 Nov 2022 | €2.6b | €624.9m | -€39,165,157.00 | 8.1x | -65.2x | 4.1x |
| Mon, 03 Oct 2022 | €2.5b | €627.4m | -€129,805,157.00 | 5.6x | -19.4x | 4x |
| Wed, 31 Aug 2022 | €2.7b | €605.7m | -€150,021,513.00 | 6x | -17.8x | 4.4x |
| Fri, 29 Jul 2022 | €3.5b | €772.0m | -€724,268,362.00 | n/a | -4.8x | 4.5x |
| Sun, 26 Jun 2022 | €3.3b | €768.8m | -€724,082,241.00 | n/a | -4.6x | 4.3x |
| Tue, 24 May 2022 | €3.3b | €768.8m | -€724,082,241.00 | n/a | -4.6x | 4.3x |
| Thu, 21 Apr 2022 | €3.7b | €808.9m | -€704,269,813.00 | n/a | -5.2x | 4.5x |
| Sat, 19 Mar 2022 | €3.6b | €806.6m | -€675,771,829.00 | n/a | -5.3x | 4.4x |
| Mon, 14 Feb 2022 | €3.7b | €789.6m | -€311,283,353.00 | n/a | -12x | 4.7x |
| Wed, 12 Jan 2022 | €4.0b | €789.6m | -€311,283,353.00 | n/a | -12.8x | 5.1x |
| Fri, 10 Dec 2021 | €4.1b | €789.6m | -€311,690,565.00 | n/a | -13.2x | 5.2x |
| Sun, 07 Nov 2021 | €4.4b | €771.2m | -€257,628,521.00 | n/a | -17.2x | 5.7x |
| Tue, 05 Oct 2021 | €4.3b | €768.9m | -€232,876,055.00 | n/a | -18.3x | 5.6x |
| Thu, 02 Sep 2021 | €4.3b | €769.4m | -€175,243,228.00 | 1.4x | -24.8x | 5.6x |
| Sat, 31 Jul 2021 | €4.4b | €769.4m | -€175,243,228.00 | 1.4x | -25x | 5.7x |
Price to Earnings Ratio
-23x
Current Industry PE
- Investors are pessimistic on the German Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 13.7x which is higher than its 3-year average PE of -20.8x.
- The 3-year average PS ratio of 4.5x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- Total earnings for the Biotechnology industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 6.0% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does German Biotech compare with similar industries?
| DE Market | -0.43% | |
| Healthcare | 1.61% | |
| Biotech | 0.63% | |
| Biotech | 0.63% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MOR MorphoSys | €69.35 | 3.5% +€88.5m | 203.4% | PS10.8x | |
| FYB Formycon | €44.30 | 3.6% +€27.4m | -43.0% | PE10.3x | |
| 7V0 Darwin | €36.20 | 0.6% +€600.0k | -15.8% | n/a | |
| 2INV 2invest | €8.65 | 1.2% +€574.8k | 33.1% | PE31.5x | |
| T5O bioXXmed | €0.50 | 23.2% +€482.9k | -74.6% | PS125.2x |